Notice for International Patients & Caregivers

English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.

Provincial Landscape
Snapshot: 2026-09-04

Shandong Multiple Myeloma Active Trials & Centers

As of 2026-09-04, there are 39 active clinical trials for multiple myeloma hosted across 28 tertiary medical centers in Shandong (including 山东省肿瘤医院, 青岛市立医院, Heze Municipal Hospital, etc.).

Active Trials
39
Hospitals
28
Therapies
CAR-T Cell Therapy / Bispecific & Multispecific Antibodies / Monoclonal Antibodies / Oral Small-Molecule Agents

Participating Medical Centers (28)

山东省肿瘤医院青岛市立医院Heze Municipal HospitalBinzhou Medical University HospitalShandong Provincial HospitalShandong Cancer Hospital Affiliated to Shandong First Medical UniversityShandong Provincial Hospital Affiliated to Shandong First Medical University (Shandong Provincial Hospital)The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)Shandong Cancer Hospital and Institute (Shandong Cancer Hospital Affiliated to Shandong First Medical University)Qingdao Central Hospital, University of Health and Rehabilitation SciencesJining No. 1 People's HospitalAffiliated Hospital of Jining Medical UniversityWeifang People's HospitalThe Second Affiliated Hospital of Shandong First Medical University (The Second Clinical Medical College)PKU Healthcare Luzhong HospitalThe Affiliated Hospital of Qingdao UniversityQilu Hospital of Shandong UniversityYantai Yuhuangding HospitalQingdao Municipal Hospital (Qingdao Beijiushui Sanatorium)Linyi Central HospitalLinyi Cancer HospitalRizhao People's HospitalLiaocheng People's HospitalThe Second Hospital of Shandong UniversityQingdao Municipal HospitalLinyi People's HospitalTai'an City Central HospitalZibo Central Hospital

Active Studies in Shandong (39)

Population synthesized by CMDN

Showing 0 published English records of 39 registry trials.

All 39 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.